Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sushama Talegaonkar

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Journal of Drug Targeting|July 5, 2018
Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an <i>in-vitro</i>, <i>in-vivo</i> and mechanistic investigationLalit Mohan Negi, Sushama Talegaonkar, Manu Jaggi, et al.
Pharmaceutical Nanotechnology|December 6, 2019
WITHDRAWN: Appraisal of Bone Targeting Potential of Nanohydroxyapatite Based Drug Carriers Conjugated with Pamidronate in Osteoporosis TreatmentPurnima Rawat, Shindu C Thomas, Farhan Jalees Ahmad, et al.
AAPS Pharmscitech|September 17, 2009
Nanocarrier for the transdermal delivery of an antiparkinsonian drugAdnan Azeem, Farhan J Ahmad, Roop K Khar, et al.
International Journal of Biological Macromolecules|December 6, 2014
Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancerLalit Mohan Negi, Manu Jaggi, Vidushi Joshi, et al.
International Journal of Pharmaceutics|May 8, 2016
Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studiesAbrar M Khan, Farhan Jalees Ahmad, Amulya K Panda, et al.
Medical Hypotheses|June 1, 2016
Nanofacilitated synergistic treatment for rheumatoid arthritis: A 'three-pronged' approachShweta Pandey, Nishant Rai, Purnima Rawat, et al.
AAPS Pharmscitech|September 7, 2017
Appraisal of Transdermal Water-in-Oil Nanoemulgel of Selegiline HCl for the Effective Management of Parkinson's Disease: Pharmacodynamic, Pharmacokinetic, and Biochemical InvestigationsSonal Setya, Tushar Madaan, Mohammad Tariq, et al.
Current Pharmaceutical Biotechnology|August 5, 2019
Structure, Genome, Infection Cycle and Clinical Manifestations Associated with Human PapillomavirusSrishti Vashisht, Harshita Mishra, Pawan K Mishra, et al.
Medical Hypotheses|November 7, 2018
Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticleLubna Siddiqui, Harshita Mishra, Pawan Kumar Mishra, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 25, 2023
Uncovering caregiver concerns: 5 key issues that still remain unresolved in administration of oral medicines for children in IndiaSushama Talegaonkar, Ayushi Chitlangia, Varsha Pradhan, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Journal of Drug Targeting|July 5, 2018
Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an <i>in-vitro</i>, <i>in-vivo</i> and mechanistic investigationLalit Mohan Negi, Sushama Talegaonkar, Manu Jaggi, et al.
Pharmaceutical Nanotechnology|December 6, 2019
WITHDRAWN: Appraisal of Bone Targeting Potential of Nanohydroxyapatite Based Drug Carriers Conjugated with Pamidronate in Osteoporosis TreatmentPurnima Rawat, Shindu C Thomas, Farhan Jalees Ahmad, et al.
AAPS Pharmscitech|September 17, 2009
Nanocarrier for the transdermal delivery of an antiparkinsonian drugAdnan Azeem, Farhan J Ahmad, Roop K Khar, et al.
International Journal of Biological Macromolecules|December 6, 2014
Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancerLalit Mohan Negi, Manu Jaggi, Vidushi Joshi, et al.
International Journal of Pharmaceutics|May 8, 2016
Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studiesAbrar M Khan, Farhan Jalees Ahmad, Amulya K Panda, et al.
Medical Hypotheses|June 1, 2016
Nanofacilitated synergistic treatment for rheumatoid arthritis: A 'three-pronged' approachShweta Pandey, Nishant Rai, Purnima Rawat, et al.
AAPS Pharmscitech|September 7, 2017
Appraisal of Transdermal Water-in-Oil Nanoemulgel of Selegiline HCl for the Effective Management of Parkinson's Disease: Pharmacodynamic, Pharmacokinetic, and Biochemical InvestigationsSonal Setya, Tushar Madaan, Mohammad Tariq, et al.
Current Pharmaceutical Biotechnology|August 5, 2019
Structure, Genome, Infection Cycle and Clinical Manifestations Associated with Human PapillomavirusSrishti Vashisht, Harshita Mishra, Pawan K Mishra, et al.
Medical Hypotheses|November 7, 2018
Novel 4-in-1 strategy to combat colon cancer, drug resistance and cancer relapse utilizing functionalized bioinspiring lignin nanoparticleLubna Siddiqui, Harshita Mishra, Pawan Kumar Mishra, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 25, 2023
Uncovering caregiver concerns: 5 key issues that still remain unresolved in administration of oral medicines for children in IndiaSushama Talegaonkar, Ayushi Chitlangia, Varsha Pradhan, et al.
Pageof 11